2025
Evidence-based personalised medicine in critical care: a framework for quantifying and applying individualised treatment effects in patients who are critically ill
Munroe E, Spicer A, Castellvi-Font A, Zalucky A, Dianti J, Linck E, Talisa V, Urner M, Angus D, Baedorf-Kassis E, Blette B, Bos L, Buell K, Casey J, Calfee C, Del Sorbo L, Estenssoro E, Ferguson N, Giblon R, Granholm A, Harhay M, Heath A, Hodgson C, Houle T, Jiang C, Kramer L, Lawler P, Leligdowicz A, Li F, Liu K, Maiga A, Maslove D, McArthur C, McAuley D, Neto A, Oosthuysen C, Perner A, Prescott H, Rochwerg B, Sahetya S, Samoilenko M, Schnitzer M, Seitz K, Shah F, Shankar-Hari M, Sinha P, Slutsky A, Qian E, Webb S, Young P, Zampieri F, Zarychanski R, Fan E, Semler M, Churpek M, Goligher E, investigators P, Group E. Evidence-based personalised medicine in critical care: a framework for quantifying and applying individualised treatment effects in patients who are critically ill. The Lancet Respiratory Medicine 2025, 13: 556-568. PMID: 40250459, PMCID: PMC12362495, DOI: 10.1016/s2213-2600(25)00054-2.Peer-Reviewed Original ResearchConceptsAverage treatment effectCritical careHeterogeneity of treatment effectsTreatment decisionsTreatment effectsCritical care syndromesResponse to treatmentClinical careRandomised clinical trialsCareRandomised trialsEffects of treatmentTreatment responseClinical trialsAggregate differencesPatientsOutcomesPersonalised medicineTreatmentEffect ITrials
2024
Sample size and power calculation for testing treatment effect heterogeneity in cluster randomized crossover designs
Wang X, Chen X, Goldfeld K, Taljaard M, Li F. Sample size and power calculation for testing treatment effect heterogeneity in cluster randomized crossover designs. Statistical Methods In Medical Research 2024, 33: 1115-1136. PMID: 38689556, PMCID: PMC11347095, DOI: 10.1177/09622802241247736.Peer-Reviewed Original ResearchCluster randomized crossover designSample size formulaTreatment effect heterogeneityAverage treatment effectHeterogeneity of treatment effectsSize formulaRandomized crossover designCluster-randomized crossover trialRandomized crossover trialEffect heterogeneitySampling schemeCluster randomized designTreatment effectsDifferential treatment effectsCrossover designFormulaContinuous outcomesLinear mixed modelsSample sizeCrossover trialInteraction testMixed modelsCovariatesClinical characteristicsStatistical methods
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply